InvestorsHub Logo
Followers 827
Posts 119499
Boards Moderated 15
Alias Born 09/05/2002

Re: boraborak38 post# 214

Thursday, 02/16/2023 8:10:00 PM

Thursday, February 16, 2023 8:10:00 PM

Post# of 245
What the CEO clearly means by the "not included" comment is that the existence of the double-dose option is not going to increase Jeuveau sales relative to what they would have been if the double-dose study had never been conducted.

Management must have thought the double-dose study would boost the company's share price, but that didn't happen because investors rightfully saw it as a gimmick. I predict that EOLS will have very little, if anything, to say about this topic when the "final analysis" is completed.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EOLS News